Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EYETECH PHARMACEUTICALS INC | 909,385 | reported | 26 May 2004 | tx 15+1,467,582−1,807,732 |
| CORCEPT THERAPEUTICS INC | 41,250 | reported | 05 Apr 2010 | tx 14+718,105−41,250 |
| ChemoCentryx, Inc. | 12,500 | reported | 23 May 2013 | tx 11+1,893,088−3,736,177 |
| IDM PHARMA, INC. | 10,000 | reported | 25 Jun 2008 | tx 10+36,829−1,442,692 |
| CymaBay Therapeutics, Inc. | 9,000 | reported | 07 Jan 2015 | tx 4+20,675 |
| SCYNEXIS INC | 8,800 | reported | 04 Jun 2015 | tx 2+12,280 |
| CHIRON CORP | 3,233 | reported | 19 Apr 2006 | tx 6+6,619−233,190 |
| SUNESIS PHARMACEUTICALS INC | 0 | reported | 14 Dec 2009 | tx 3−2,232,464 |
| RENOVIS INC | 0 | reported | 02 May 2008 | tx 27+2,248,006−11,865,302 |
| ZYMOGENETICS INC | 0 | reported | 08 Oct 2010 | tx 9+135,000−144,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Apr 2019 | OTHER | Immune Design Corp. | 12,500 | — | deriv |
| 02 Apr 2019 | OTHER | Immune Design Corp. | 12,500 | — | deriv |
| 02 Apr 2019 | OTHER | Immune Design Corp. | 10,000 | — | deriv |
| 02 Apr 2019 | OTHER | Immune Design Corp. | 4,281 | — | deriv |
| 02 Apr 2019 | OTHER | Immune Design Corp. | 3,058 | — | deriv |
| 03 Jan 2019 | GRANT_AWARD | Immune Design Corp. | 12,500 | 0.00 USD | deriv |
| 04 Jan 2018 | GRANT_AWARD | Immune Design Corp. | 12,500 | 0.00 USD | deriv |
| 04 Jan 2017 | GRANT_AWARD | Immune Design Corp. | 10,000 | 0.00 USD | deriv |
| 04 Jan 2016 | GRANT_AWARD | Immune Design Corp. | 9,300 | 0.00 USD | deriv |
| 04 Jun 2015 | GRANT_AWARD | SCYNEXIS INC | 8,800 | 0.00 USD | deriv |
| 07 Jan 2015 | GRANT_AWARD | Immune Design Corp. | 9,300 | 0.00 USD | deriv |
| 07 Jan 2015 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 29 Jul 2014 | CONVERSION | Immune Design Corp. | 531,843 | — | |
| 29 Jul 2014 | CONVERSION | Immune Design Corp. | 305,810 | — | |
| 29 Jul 2014 | PURCHASE | Immune Design Corp. | 299,559 | 12.00 USD | first after silence |
| 29 Jul 2014 | CONVERSION | Immune Design Corp. | 733,943 | — | |
| 29 Jul 2014 | CONVERSION | Immune Design Corp. | 611,620 | — | |
| 29 Jul 2014 | CONVERSION | Immune Design Corp. | 733,943 | 0.00 USD | deriv |
| 29 Jul 2014 | CONVERSION | Immune Design Corp. | 531,843 | 0.00 USD | deriv |
| 29 Jul 2014 | CONVERSION | Immune Design Corp. | 305,810 | 0.00 USD | deriv |
| 29 Jul 2014 | EXERCISE | Immune Design Corp. | 305,810 | 0.00 USD | deriv |
| 29 Jul 2014 | EXERCISE | Immune Design Corp. | 305,810 | 0.00 USD | deriv |
| 29 Jul 2014 | CONVERSION | Immune Design Corp. | 611,620 | 0.00 USD | deriv |
| 11 Jun 2014 | GRANT_AWARD | SCYNEXIS INC | 3,480 | 0.00 USD | deriv |
| 23 Dec 2013 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 2,335 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 29 Jul 2014.